[Organic solvent-related mental disorders].
Suetsugu
Sachiko
S
Hasegawa Hospital.
Morita
Nobuaki
N
D000280:Administration, Inhalation; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D038801:International Classification of Diseases; D011939:Mental Recall; D011613:Psychotherapy; D012657:Self-Help Groups; D012677:Sensation; D012944:Social Support; D012997:Solvents / Q000008:administration & dosage / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D012997:Solvents; D002220:Carbamazepine; D014635:Valproic Acid; D006220:Haloperidol